Statistics for Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
Total visits
| views | |
|---|---|
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial | 241 |
Total visits per month
| views | |
|---|---|
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| TICO.pdf | 461 |
| TICO.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 177 |
| China | 14 |
| Germany | 10 |
| Ireland | 5 |
| United Kingdom | 4 |
| Hong Kong SAR China | 3 |
| France | 2 |
| Japan | 2 |
| Philippines | 2 |
| Ukraine | 2 |
| Armenia | 1 |
| Australia | 1 |
| Egypt | 1 |
| Spain | 1 |
| Finland | 1 |
| Indonesia | 1 |
| Malawi | 1 |
| Mexico | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
| Poland | 1 |
| Russia | 1 |
| Singapore | 1 |
| Thailand | 1 |
| Taiwan | 1 |
| Uruguay | 1 |
Top city views
| views | |
|---|---|
| Reston | 127 |
| Ashburn | 7 |
| Beijing | 5 |
| Los Angeles | 5 |
| Christiansburg | 4 |
| Qingdao | 3 |
| Boydton | 2 |
| Castro Valley | 2 |
| Central | 2 |
| Dublin | 2 |
| Fremont | 2 |
| Odesa | 2 |
| Bangkok | 1 |
| Barcelona | 1 |
| Bethesda | 1 |
| Boardman | 1 |
| Buffalo | 1 |
| Cairo | 1 |
| Charlottesville | 1 |
| Chicago | 1 |
| Dayton | 1 |
| Durham | 1 |
| Guangzhou | 1 |
| Hsinchu | 1 |
| Lahore | 1 |
| Lilongwe | 1 |
| London | 1 |
| Mountain View | 1 |
| Munich | 1 |
| Norwich | 1 |
| Novosibirsk | 1 |
| Petaling Jaya | 1 |
| San Jose | 1 |
| Shenyang | 1 |
| Shenzhen | 1 |
| Silver Spring | 1 |
| Tarlac City | 1 |
| Tokyo | 1 |
| Tranent | 1 |
| Wake Forest | 1 |
| Warsaw | 1 |
| Xi'an | 1 |
| Yerevan | 1 |
| Yogyakarta | 1 |
| Zhengzhou | 1 |